Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 2Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 14Genitourinary 12Gastrointestinal 12Thoracic 10Gynecologic 9CNS 9Other hematologic neoplasm 7Other solid neoplasm 6Lymphoid 6Plasma cell 5Tumor-Agnostic 2Sarcoma 2Other 2Dermatologic 2NET 1Endocrine 1Classical hematology 1

Conditions

Neoplastic Syndromes, Hereditary 1Hematologic Neoplasms 1Cytopenia 1Congenital Bone Marrow Failure Syndromes 1Bone Marrow Failure Disorders 1

Interventions

fludarabine phosphate 9Cyclophosphamide 8Cyclosporine 7Busulfan 6Antilymphocyte Serum 6fludarabine 5Melphalan 5Peripheral Blood Stem Cell Transplantation 4Mycophenolic Acid 4Rivaroxaban 3Radiotherapy 3Methylprednisolone 3Filgrastim 3Cord Blood Stem Cell Transplantation 3thymoglobulin 2ferric carboxymaltose 2apixaban 2Whole-Body Irradiation 2Therapeutics 2Methotrexate 2Heparin, Low-Molecular-Weight 2Hematologic Tests 2Genetic Counseling 2Fondaparinux 2Enoxaparin 2Educational Status 2Drug Therapy 2Dalteparin 2Cytarabine 2sulforaphane 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Specimen Handling × Classical hematology × Clear all
NCT02958462 2026-02-23

Pre-myeloid Cancer and Bone Marrow Failure Clinic Study

Mayo Clinic

Phase NA Recruiting
2,000 enrolled
Classical hematologyOther hematologic neoplasm

Bone Marrow Failure Disorders, Congenital Bone Marrow Failure Syndromes, Cytopenia, Neoplastic Syndromes, Hereditary, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡